OK, let’s not muck about. This is very serious. It’s just over 100 days until the first Ashes Test in Perth, the Poms ...

You might think sticking out your gyatt for the rizzler is chopped, but “Algospeak” author Adam Aleksic says we should let ...

The biggest online beauty discourse of the past two weeks may be known on TikTok as mere “OPI nail drama,” but it’s brought ...

One minute you’re vibing to Chris Martin’s sultry and sweet modern-pop-rock poetry at the Coldplay concert, getting all up on ...

SoFi targets millennials with bold crypto and private equity moves, expanding beyond student loans amid rising distrust. Read ...

Appoint Wiegman and Carsley Lee Carsley back to back U21 Euros winner with England. Sarina Wiegman back to women’s Euros ...

Wall Street inched to more records as gains for Alphabet and artificial-intelligence stocks helped make up for Tesla’s steep ...

Roche’s breast cancer drug Kadcyla is set for regular NHS funding in England after the company finally agreed a deal with NICE. The row over Kadcyla has lasted three years, and has been one of ...

U.S. stocks are rising toward more records following a trade deal between the world’s No. 1 and No. 4 economies. The S&P 500 ...

Gains for several big tech companies helped nudge U.S. indexes to more records even as most stocks in the market fell. The ...

Price cut persuades NICE to back AstraZeneca’s Tagrisso for first-line use in lung cancer, but there’s bad news for drugs from Celgene and Pfizer ...

U.S. stocks are ticking toward another record following a trade deal between the world’s No. 1 and No. 4 economies. The S&P ...